Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Prelude Therapeutics (PRLD)
NASDAQ:PRLD
RESEARCH TOOLSreports
Prelude Therapeutics (PRLD) Ownership - Who Owns Prelude Therapeutics?
99 Followers
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| May 26, 2023 | Krishna Vaddi Ceo,director | Bought | $9789 |
| May 25, 2023 | Krishna Vaddi Ceo,director | Bought | $66749 |
| May 25, 2023 | Bryant David Lim Clo, Corp Sec | Bought | $12936 |
| May 24, 2023 | Orbimed Advisors Llc Director, >10% Owner | Bought | $4999999 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2023 | Bought | $17647910 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,123,824 | Institution | 18.43% | 47,986,926 | |
| 4,133,000 | Institution | 7.53% | 19,590,420 | |
| 1,068,192 | Institution | 1.94% | 5,063,230 | |
| 980,299 | Institution | 1.78% | 4,646,617 | |
| 918,442 | Institution | 1.67% | 4,353,415 | |
| 894,468 | Institution | 1.63% | 4,239,778 | |
| 771,093 | Institution | 1.40% | 3,654,981 | |
| 525,946 | Institution | 0.96% | 2,492,984 | |
| 466,518 | Institution | 0.85% | 2,211,295 | |
| 442,180 | Institution | 0.81% | 2,095,933 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,068,192 | Institution | 1.94% | 5,063,230 | |
| 918,442 | Institution | 1.67% | 4,353,415 | |
| 894,468 | Institution | 1.63% | 4,239,778 | |
| 771,093 | Institution | 1.40% | 3,654,981 | |
| 466,518 | Institution | 0.85% | 2,211,295 | |
| 442,180 | Institution | 0.81% | 2,095,933 | |
| 335,102 | Institution | 0.61% | 1,588,383 | |
| 327,699 | Institution | 0.60% | 1,553,293 | |
| 254,056 | Institution | 0.46% | 1,204,225 | |
| 160,507 | Institution | 0.29% | 760,803 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 720,427 | Institution | 1.31% | 3,097,836 | |
| 358,180 | Institution | 0.65% | 1,697,773 | |
| 198,134 | Institution | 0.36% | 851,976 | |
| 135,613 | Institution | 0.25% | 642,806 | |
| 77,193 | Institution | 0.14% | 368,211 | |
| 67,293 | Institution | 0.12% | 320,988 | |
| 52,522 | Institution | 0.10% | 225,845 | |
| 32,153 | Institution | 0.06% | 152,405 | |
| 9,187 | Institution | 0.02% | 43,822 | |
| 9,216 | Institution | 0.02% | 39,629 |
FAQ
Who Owns Prelude Therapeutics (PRLD)?
Currently, no data Available
What percentage of Prelude Therapeutics (PRLD) stock is held by institutional investors?
Currently, no data Available
What percentage of Prelude Therapeutics (PRLD) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Prelude Therapeutics (PRLD)?
Felix Baker owns the most shares of Prelude Therapeutics (PRLD).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.